✉ Email this page to a colleague
« Back to Dashboard
Carbinoxamine maleateis the generic ingredient in three branded drugs marketed by Mcneil, Cypress Pharm, Genus, Vintage Pharms, Aytu, Invagen Pharms, Mikart, Mission Pharmacal, Strides Pharma, and Ortho Mcneil Pharm, and is included in twelve NDAs. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.
Carbinoxamine maleate has twenty-one patent family members in fourteen countries.
There are seven drug master file entries for carbinoxamine maleate. Six suppliers are listed for this compound.
Summary for carbinoxamine maleate
|Drug Master File Entries:||7|
|Finished Product Suppliers / Packagers:||6|
|Raw Ingredient (Bulk) Api Vendors:||62|
|Drug Prices:||Drug price trends for carbinoxamine maleate|
|Patent Litigation and PTAB cases:||See patent lawsuits and PTAB cases for carbinoxamine maleate|
|What excipients (inactive ingredients) are in carbinoxamine maleate?||carbinoxamine maleate excipients list|
|DailyMed Link:||carbinoxamine maleate at DailyMed|
Pharmacology for carbinoxamine maleate
|Drug Class||Histamine-1 Receptor Antagonist|
|Mechanism of Action||Histamine H1 Receptor Antagonists|
Anatomical Therapeutic Chemical (ATC) Classes for carbinoxamine maleate
|Country||Patent Number||Title||Estimated Expiration|
|Denmark||2428205||⤷ Try a Trial|
|Russian Federation||2008140944||КОМПОЗИЦИИ С МОДИФИЦИРОВАННЫМ ВЫСВОБОЖДЕНИЕМ, СОДЕРЖАЩИЕ КОМПЛЕКСЫ ЛЕКАРСТВЕННОЕ ВЕЩЕСТВО-ИОНООБМЕННАЯ СМОЛА||⤷ Try a Trial|
|World Intellectual Property Organization (WIPO)||2007109104||⤷ Try a Trial|
|Australia||2007227569||Modified release formulations containing drug-ion exchange resin complexes||⤷ Try a Trial|
|Israel||194042||פורמולציות לשחרור שונה המכילות קומפלקסים של תרופה ורזין מחליף יונים (Modified release formulations containing drug-ion exchange resin complexes)||⤷ Try a Trial|
|European Patent Office||2018160||FORMULATIONS A LIBERATION MODIFIEE CONTENANT DES COMPLEXES MEDICAMENT - RESINE ECHANGEUSE D'IONS (MODIFIED RELEASE FORMULATIONS CONTAINING DRUG-ION EXCHANGE RESIN COMPLEXES)||⤷ Try a Trial|
|Japan||5479086||⤷ Try a Trial|
|>Country||>Patent Number||>Title||>Estimated Expiration|
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.